NCT07146425Recruiting
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
Source: ClinicalTrials.gov · Last updated 28 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This research is a single-center, exploratory, observational study to be carried out in the outpatient or inpatient ward of the Neurology Department at Huashan Hospital, affiliated to Fudan University. The aim is to develop a digital assessment model for Myasthenia Gravis by gathering multimodal digital phenotypic data from MG patients. This includes physiological signals, facial videos, eye movements, speech, limb movements, various scales, and quality of life metrics.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 180 (estimated)
- First submitted
- 19 Jul 2024
- Start date
- 31 Aug 2023
- Primary completion date
- Dec 2025
- Lead sponsor
- Huashan Hospital
- Diseases
- Myasthenia gravis
- NCT number
- NCT07146425
What you commit to
- Study type: Observational
- Planned participants: 180
- From 31 Aug 2023 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients are with severe cardiopulmonary diseases and unable to cooperate with the scoring.
- Patients with any psychiatric disorder or cognitive dysfunction that, in the investigator's judgment, may interfere with their participation in the study.
- Patients with any other unspecified unstable medical condition.
Other
- For Patients with MG
- Patients are in the crisis stage of myasthenia gravis (MGFA class V) and unable to cooperate with scoring.
Who the study is looking for
- For Patients with MG
- Patients have a confirmed diagnosis of myasthenia gravis and be over 18 years old.
- Patients have the clinical classification of Myasthenia Gravis Foundation of America (MGFA) within I-IV, or be asymptomatic after treatment.
- Patients must sign the informed consent form and the privacy confidentiality agreement.
- For Healthy Participants
- Age group matched with MG participants
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Huashan Hospital Affiliated to Fudan University Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.